Please enable JavaScript to continue using this application.

Compare $ARQT vs $RCUS | Chartloom

Compare

$ARQT vs $RCUS

Arcutis Biotherapeutics Inc · Arcus Biosciences Inc

ARQT

Arcutis Biotherapeutics Inc

RCUS

Arcus Biosciences Inc

Compare $ARQT vs $RCUS

Comparing Arcutis Biotherapeutics Inc and Arcus Biosciences Inc

ARQTArcutis Biotherapeutics Inc

RCUSArcus Biosciences Inc

ARQTArcutis Biotherapeutics Inc

Market cap

$3.32B

P/E (TTM)

126.66x

Forward P/E (NTM)

34.71x

Forward P/S (NTM)

5.40x

Rev growth (TTM)

76.1%

YTD performance

-8.3%

52W performance

25.1%

FCF yield

1.2%

RCUSArcus Biosciences Inc

Market cap

$3.07B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

84.08x

Rev growth (TTM)

-55.3%

YTD performance

4.8%

52W performance

62.2%

FCF yield

-15.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARQT

RCUS

Detailed metrics comparison

ARQT

Arcutis Biotherapeutics Inc

RCUS

Arcus Biosciences Inc

Market Cap

ARQT$3.32B

RCUS$3.07B

Enterprise Value

ARQT$3.40B

RCUS$3.02B

Price

ARQT$26.58

RCUS$24.41

P/E Ratio

ARQT126.66x

RCUSN/A

P/S Ratio

ARQT7.17x

RCUS26.24x

EV/Sales

ARQT7.33x

RCUS25.82x

EV/EBITDA

ARQT87.53x

RCUS37.63x

P/B Ratio

ARQT14.34x

RCUS6.71x

P/FCF Ratio

ARQT84.92x

RCUSN/A

EV/FCF

ARQT86.83x

RCUS-6.36x

PEG Ratio

ARQTN/A

RCUSN/A

Forward P/E (NTM)

ARQT34.71x

RCUSN/A

Forward P/S (NTM)

ARQT5.40x

RCUS84.08x

Revenue (TTM)

ARQT$464M

RCUS$117M

Revenue Growth (YoY)

ARQT76.1%

RCUS-55.3%

Forward Rev Growth

ARQT27.7%

RCUS-34.4%

Gross Margin (TTM)

ARQT91.1%

RCUS0.0%

Operating Margin (TTM)

ARQT7.4%

RCUS0.0%

EBITDA Margin (TTM)

ARQT7.9%

RCUS-406.8%

Net Margin (TTM)

ARQT6.1%

RCUS-393.2%

FCF Margin (TTM)

ARQT8.4%

RCUS-406.0%

Net Income (TTM)

ARQT$29M

RCUS$-460M

FCF (TTM)

ARQT$39M

RCUS$-475M

EPS (TTM)

ARQT$0.21

RCUS-$3.65

ROE (TTM)

ARQT15.0%

RCUS-8954.0%

ROA (TTM)

ARQT6.5%

RCUS-4561.0%

ROIC (TTM)

ARQT9.6%

RCUS-7501.0%

Cash

ARQT$34M

RCUS$150M

Debt

ARQT$109M

RCUS$101M

Net Cash/Debt

ARQT$-75M

RCUS$49M

Current Ratio (TTM)

ARQT2.92x

RCUS3.82x

Quick Ratio (TTM)

ARQT2.46x

RCUS3.75x

Debt/Equity (TTM)

ARQT0.49x

RCUS0.22x

Debt/Assets (TTM)

ARQT0.0%

RCUS0.0%

Interest Coverage (TTM)

ARQTN/A

RCUSN/A

Net Debt/EBITDA (TTM)

ARQT0.00x

RCUS0.00x

Beta

ARQT1.66

RCUS1.05

52W Performance

ARQT25.1%

RCUS62.2%

YTD Performance

ARQT-8.3%

RCUS4.8%

% from 52W High

ARQT-16.3%

RCUS-23.1%

% from 52W Low

ARQT37.8%

RCUS71.2%

Asset Turnover (TTM)

ARQT1.06x

RCUS0.12x

FCF Yield (TTM)

ARQT1.2%

RCUS-15.5%

Earnings Yield (TTM)

ARQT0.9%

RCUS-15.0%

Dividend Yield (TTM)

ARQTN/A

RCUSN/A

Rule of 40

ARQT84.5

RCUS-461.3

EV/GP/RG

ARQT0.23

RCUSN/A

Ticker research

View ARQT research View RCUS research

Metric	ARQT Arcutis Biotherapeutics Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.32B	$3.07B
Enterprise Value	$3.40B	$3.02B
Price	$26.58	$24.41
P/E Ratio	126.66x	N/A
P/S Ratio	7.17x	26.24x
EV/Sales	7.33x	25.82x
EV/EBITDA	87.53x	37.63x
P/B Ratio	14.34x	6.71x
P/FCF Ratio	84.92x	N/A
EV/FCF	86.83x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	34.71x	N/A
Forward P/S (NTM)	5.40x	84.08x
Revenue & Growth
Revenue (TTM)	$464M	$117M
Revenue Growth (YoY)	76.1%	-55.3%
Forward Rev Growth	27.7%	-34.4%
Profitability
Gross Margin (TTM)	91.1%	0.0%
Operating Margin (TTM)	7.4%	0.0%
EBITDA Margin (TTM)	7.9%	-406.8%
Net Margin (TTM)	6.1%	-393.2%
FCF Margin (TTM)	8.4%	-406.0%
Net Income (TTM)	$29M	$-460M
FCF (TTM)	$39M	$-475M
EPS (TTM)	$0.21	-$3.65
ROE (TTM)	15.0%	-8954.0%
ROA (TTM)	6.5%	-4561.0%
ROIC (TTM)	9.6%	-7501.0%
Financial Health
Cash	$34M	$150M
Debt	$109M	$101M
Net Cash/Debt	$-75M	$49M
Current Ratio (TTM)	2.92x	3.82x
Quick Ratio (TTM)	2.46x	3.75x
Debt/Equity (TTM)	0.49x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.05
52W Performance	25.1%	62.2%
YTD Performance	-8.3%	4.8%
% from 52W High	-16.3%	-23.1%
% from 52W Low	37.8%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.12x
FCF Yield (TTM)	1.2%	-15.5%
Earnings Yield (TTM)	0.9%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	84.5	-461.3
EV/GP/RG	0.23	N/A
Ticker research	View ARQT research	View RCUS research

Valuation

P/E Ratio

ARQT

126.66x

P/S Ratio

ARQT

7.17x

RCUS

26.24x

EV/FCF

RCUS

-6.36x

ARQT

86.83x

Growth & revenue

Revenue Growth TTM

ARQT

76.1%

RCUS

-55.3%

Forward Revenue Growth

ARQT

27.7%

RCUS

-34.4%

Profitability & performance

Gross Margin

ARQT

91.1%

RCUS

0.0%

ROE

ARQT

15.0%

RCUS

-8954.0%

FCF Yield %

ARQT

1.2%

RCUS

-15.5%

52-Week Performance

RCUS

62.2%

ARQT

25.1%

Detailed metrics comparison

ARQT

Arcutis Biotherapeutics Inc

RCUS

Arcus Biosciences Inc

Market Cap

ARQT$3.32B

RCUS$3.07B

Enterprise Value

ARQT$3.40B

RCUS$3.02B

Price

ARQT$26.58

RCUS$24.41

P/E Ratio

ARQT126.66x

RCUSN/A

P/S Ratio

ARQT7.17x

RCUS26.24x

EV/Sales

ARQT7.33x

RCUS25.82x

EV/EBITDA

ARQT87.53x

RCUS37.63x

P/B Ratio

ARQT14.34x

RCUS6.71x

P/FCF Ratio

ARQT84.92x

RCUSN/A

EV/FCF

ARQT86.83x

RCUS-6.36x

PEG Ratio

ARQTN/A

RCUSN/A

Forward P/E (NTM)

ARQT34.71x

RCUSN/A

Forward P/S (NTM)

ARQT5.40x

RCUS84.08x

Revenue (TTM)

ARQT$464M

RCUS$117M

Revenue Growth (YoY)

ARQT76.1%

RCUS-55.3%

Forward Rev Growth

ARQT27.7%

RCUS-34.4%

Gross Margin (TTM)

ARQT91.1%

RCUS0.0%

Operating Margin (TTM)

ARQT7.4%

RCUS0.0%

EBITDA Margin (TTM)

ARQT7.9%

RCUS-406.8%

Net Margin (TTM)

ARQT6.1%

RCUS-393.2%

FCF Margin (TTM)

ARQT8.4%

RCUS-406.0%

Net Income (TTM)

ARQT$29M

RCUS$-460M

FCF (TTM)

ARQT$39M

RCUS$-475M

EPS (TTM)

ARQT$0.21

RCUS-$3.65

ROE (TTM)

ARQT15.0%

RCUS-8954.0%

ROA (TTM)

ARQT6.5%

RCUS-4561.0%

ROIC (TTM)

ARQT9.6%

RCUS-7501.0%

Cash

ARQT$34M

RCUS$150M

Debt

ARQT$109M

RCUS$101M

Net Cash/Debt

ARQT$-75M

RCUS$49M

Current Ratio (TTM)

ARQT2.92x

RCUS3.82x

Quick Ratio (TTM)

ARQT2.46x

RCUS3.75x

Debt/Equity (TTM)

ARQT0.49x

RCUS0.22x

Debt/Assets (TTM)

ARQT0.0%

RCUS0.0%

Interest Coverage (TTM)

ARQTN/A

RCUSN/A

Net Debt/EBITDA (TTM)

ARQT0.00x

RCUS0.00x

Beta

ARQT1.66

RCUS1.05

52W Performance

ARQT25.1%

RCUS62.2%

YTD Performance

ARQT-8.3%

RCUS4.8%

% from 52W High

ARQT-16.3%

RCUS-23.1%

% from 52W Low

ARQT37.8%

RCUS71.2%

Asset Turnover (TTM)

ARQT1.06x

RCUS0.12x

FCF Yield (TTM)

ARQT1.2%

RCUS-15.5%

Earnings Yield (TTM)

ARQT0.9%

RCUS-15.0%

Dividend Yield (TTM)

ARQTN/A

RCUSN/A

Rule of 40

ARQT84.5

RCUS-461.3

EV/GP/RG

ARQT0.23

RCUSN/A

Ticker research

View ARQT research View RCUS research

Metric	ARQT Arcutis Biotherapeutics Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.32B	$3.07B
Enterprise Value	$3.40B	$3.02B
Price	$26.58	$24.41
P/E Ratio	126.66x	N/A
P/S Ratio	7.17x	26.24x
EV/Sales	7.33x	25.82x
EV/EBITDA	87.53x	37.63x
P/B Ratio	14.34x	6.71x
P/FCF Ratio	84.92x	N/A
EV/FCF	86.83x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	34.71x	N/A
Forward P/S (NTM)	5.40x	84.08x
Revenue & Growth
Revenue (TTM)	$464M	$117M
Revenue Growth (YoY)	76.1%	-55.3%
Forward Rev Growth	27.7%	-34.4%
Profitability
Gross Margin (TTM)	91.1%	0.0%
Operating Margin (TTM)	7.4%	0.0%
EBITDA Margin (TTM)	7.9%	-406.8%
Net Margin (TTM)	6.1%	-393.2%
FCF Margin (TTM)	8.4%	-406.0%
Net Income (TTM)	$29M	$-460M
FCF (TTM)	$39M	$-475M
EPS (TTM)	$0.21	-$3.65
ROE (TTM)	15.0%	-8954.0%
ROA (TTM)	6.5%	-4561.0%
ROIC (TTM)	9.6%	-7501.0%
Financial Health
Cash	$34M	$150M
Debt	$109M	$101M
Net Cash/Debt	$-75M	$49M
Current Ratio (TTM)	2.92x	3.82x
Quick Ratio (TTM)	2.46x	3.75x
Debt/Equity (TTM)	0.49x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.05
52W Performance	25.1%	62.2%
YTD Performance	-8.3%	4.8%
% from 52W High	-16.3%	-23.1%
% from 52W Low	37.8%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.12x
FCF Yield (TTM)	1.2%	-15.5%
Earnings Yield (TTM)	0.9%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	84.5	-461.3
EV/GP/RG	0.23	N/A
Ticker research	View ARQT research	View RCUS research